As per the latest report by IMARC Group, titled “Cardiovascular Information System Market Report by Type (CVIS (Cardiovascular Information System), C-PACS (Cardiology Picture Archiving and Communication System)), Component (Software, Hardware, Services), Mode of Operation (Web-based, Onsite, Cloud-based), End-User (Hospitals and Clinics, Cardiac Cath Labs, Diagnostic Centers, and Others), Application (Catheterization, Echocardiography, Electrocardiogram, Electrophysiology, Nuclear Cardiology, and Others), and Region 2025-2033,” the global cardiovascular information system market reached a value of USD 1,213.8 Million in 2024. Cardiovascular information system (CVIS) allows easy report generation and distribution and offers on-time access to cardiovascular electronic medical records (EMR) in images, reports and waveforms. It also facilitates scientific advancements, information exchange and decision support in the field of cardiovascular study. It endorses an advanced level of evidence-based professional standards in cardiac rehabilitation. At present, its demand is increasing across the globe on account of dynamic reporting, such as measurements, images and informatics, provided by CVIS. This information is further structured in a template-type manner to ensure reliability and effectiveness in delivering patient reports.
Global Cardiovascular Information System Market Trends:
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) represent one of the major causes of death globally. This can be accredited to sedentary lifestyles, rising geriatric population and the increasing prevalence of CVDs, which in turn, is positively influencing the demand for CVIS around the world. Apart from this, digitization, coupled with continuous advancements in the healthcare information technology (IT) sector, are also fueling the growth of the market. Healthcare institutions rely on CVIS to access medical data and images remotely and improve the efficiency and interoperability of diagnostic centers. Furthermore, most of the CVIS solutions provide structured reporting for all cardiology-related procedures/modalities, which is positively influencing their sales. Besides this, technological advancements, the escalating demand for data-driven technologies and extensive research and development (R&D) activities are anticipated to strengthen the market growth in the upcoming years. Looking forward, the market value is projected to reach USD 2,366.4 Million by 2033, expanding at a CAGR of 7.31% during the forecast period (2025-2033).
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Type, Component, Mode of Operation, End-User, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agfa Healthcare India Private Limited, Cerner Corporation, Digisonics Inc., Fujifilm Medical Systems, GE Healthcare, LUMEDX Corporation, McKesson Corporation, Merge Healthcare, Inc., Koninklijke Philips N.V. and Siemens Healthineers AG |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800